Trial Profile
Advancing Varenicline as a Treatment for Cannabis Use Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 31 Dec 2018 Status changed from recruiting to completed.
- 28 Dec 2018 Planned End Date changed from 13 Jun 2019 to 13 Dec 2019.
- 28 Dec 2018 Planned primary completion date changed from 13 Dec 2018 to 2 Jan 2019.